Palvella Therapeutics Inc (PVLA)
R&D Expense Growth
180.22%
Fiscal year · Period ending:
PVLA R&D Expense Growth
Latest reported180.22%period ending
Latest reported180.22%period ending
PVLA FY R&D Growth (YoY) (0.00% → 180.22%)
Latest values, visible window
High-resolution chart · PNG
PVLA r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 180.2233% | |
| -7.3013% | |
| -82.4882% | |
| -21.7845% | |
| 0% | |
| 0% |